This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Vaccination and coeliac disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • immunisations in patients with coeliac disease
    • if there is splenic deficiency (hyposplenism) then immunisation against pneumococus, meningococcal C, HIB and influenza is indicated

      • pneumococcal vaccination
        • the Coeliac Society (1) state '..Based on advice from our Health Advisory Committee, Coeliac UK recommends that everyone with coeliac disease is vaccinated against pneumococcal infection..'
        • the Green Book (2) notes that pneumococal immunisation is indicated for '...conditions such as homozygous sickle cell disease and coeliac syndrome that may lead to splenic dysfunction..' (2)

      • immunisation against haemophilus influenzae group B, meningococcal and influenza is indicated for individuals who develop asplenia or splenic dysfunction (2). There is no stated indication for these immunisations in coeliac disease patients without splenic dysfunction (2)

      • therefore in conclusion, the concensus seems to be that pneumococcal vaccination is indicated in coeliac disease per se. Other vaccines are indicated if there is hyposplenism

Reference:

  1. http://www.coeliac.org.uk/ (Accessed 12/1/13)
  2. The Green Book - Immunisation against infectious disease. Department of Health UK (Accessed 12/1/13)

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.